A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria

R. Boostani, F. Ramezanzadeh, M. Saeidi, Mina Khodabandeh
{"title":"A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria","authors":"R. Boostani, F. Ramezanzadeh, M. Saeidi, Mina Khodabandeh","doi":"10.18502/IJNL.V18I2.1290","DOIUrl":null,"url":null,"abstract":"Background: Guillain-Barre syndrome (GBS) is the major cause of acute flaccid paralysis (AFP). Comprehensive classification and predictive measures need to be created for GBS. This study was conducted to evaluate GBS patients’ prognosis and Brighton criteria validity in Iranian population. Methods: This retrospective cohort study was conducted using medical records of patients with GBS admitted to Ghaem Hospital, Mashhad, Iran. After collecting data from cerebrospinal fluid (CSF) analysis, nerve conduction studies, and clinical examinations, Brighton criteria and GBS disability scores were calculated. Patients ultimately received follow-up telephone calls after 15 to 45 months of admission, checking on one’s clinical status and the ability to walk independently. Data were analyzed using SPSS software. Results: Patients were mostly men (78.0%) with the mean age of 48.58 years. GBS onset was reported more frequently in spring. According to Brighton criteria, 41.4%, 51.6%, and 7.0% of the patients were classified as levels 1, 2, and 4, respectively. For GBS disability score, 54.7%, 16.4%, 9.4%, and 6.2% of the patients had grades of 4, 3, 2, and 1, respectively. 37 patients (39.4%) restored the ability to walk within the first month, while 3 patients (3.2%) were unable to walk by the end of the second year. Significant relationship was observed between the ability of walking independently and GBS disability score (P < 0.001). Conclusion: In the Iranian GBS population, less than half of the patients met level 1 of Brighton criteria and more than half of them reached the GBS disability score of 4, and walking ability was correlated to GBS disability score.","PeriodicalId":45759,"journal":{"name":"Iranian Journal of Neurology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/IJNL.V18I2.1290","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

Background: Guillain-Barre syndrome (GBS) is the major cause of acute flaccid paralysis (AFP). Comprehensive classification and predictive measures need to be created for GBS. This study was conducted to evaluate GBS patients’ prognosis and Brighton criteria validity in Iranian population. Methods: This retrospective cohort study was conducted using medical records of patients with GBS admitted to Ghaem Hospital, Mashhad, Iran. After collecting data from cerebrospinal fluid (CSF) analysis, nerve conduction studies, and clinical examinations, Brighton criteria and GBS disability scores were calculated. Patients ultimately received follow-up telephone calls after 15 to 45 months of admission, checking on one’s clinical status and the ability to walk independently. Data were analyzed using SPSS software. Results: Patients were mostly men (78.0%) with the mean age of 48.58 years. GBS onset was reported more frequently in spring. According to Brighton criteria, 41.4%, 51.6%, and 7.0% of the patients were classified as levels 1, 2, and 4, respectively. For GBS disability score, 54.7%, 16.4%, 9.4%, and 6.2% of the patients had grades of 4, 3, 2, and 1, respectively. 37 patients (39.4%) restored the ability to walk within the first month, while 3 patients (3.2%) were unable to walk by the end of the second year. Significant relationship was observed between the ability of walking independently and GBS disability score (P < 0.001). Conclusion: In the Iranian GBS population, less than half of the patients met level 1 of Brighton criteria and more than half of them reached the GBS disability score of 4, and walking ability was correlated to GBS disability score.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
格林-巴利综合征的随访研究及Brighton标准的验证
背景:格林-巴利综合征(GBS)是急性弛缓性麻痹(AFP)的主要病因。GBS需要建立全面的分类和预测措施。本研究旨在评估伊朗人群中GBS患者的预后和Brighton标准的有效性。方法:这项回顾性队列研究使用了伊朗马什哈德盖姆医院收治的GBS患者的医疗记录。在收集了脑脊液(CSF)分析、神经传导研究和临床检查的数据后,计算了Brighton标准和GBS残疾评分。患者最终在入院15至45个月后接到随访电话,检查自己的临床状况和独立行走能力。使用SPSS软件对数据进行分析。结果:患者多为男性(78.0%),平均年龄48.58岁。GBS的发病率在春季更高。根据Brighton标准,41.4%、51.6%和7.0%的患者分别被分为1级、2级和4级。GBS残疾评分中,54.7%、16.4%、9.4%和6.2%的患者分别为4、3、2和1级。37名患者(39.4%)在第一个月内恢复了行走能力,而3名患者(3.2%)在第二年年底无法行走。结论:在伊朗GBS人群中,不到一半的患者符合Brighton标准1级,超过一半的患者达到GBS残疾评分4,行走能力与GBS残疾分数相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Iranian Journal of Neurology
Iranian Journal of Neurology CLINICAL NEUROLOGY-
自引率
0.00%
发文量
0
期刊最新文献
Evaluation of glucose-6-phosphate dehydrogenase serum level in patients with multiple sclerosis and neuromyelitis optica. Effectiveness and side effects of dimethyl fumarate in multiple sclerosis after 12 months of follow up: An Iranian clinical trial. Thrombolytic treatment in stroke mimic, inevitable but fortunately safe: An observational study from Iran. Fitness to drive in seizure and epilepsy: A protocol for Iranian clinicians. A survey from Turkey and Iran on comparison of risk factors and etiology in ischemic stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1